IRIS Accounts Production v24.3.2.46 10342921 director 1.9.23 31.8.24 31.8.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103429212023-08-31103429212024-08-31103429212023-09-012024-08-31103429212022-08-31103429212022-09-012023-08-31103429212023-08-3110342921ns15:EnglandWales2023-09-012024-08-3110342921ns14:PoundSterling2023-09-012024-08-3110342921ns10:Director12023-09-012024-08-3110342921ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3110342921ns10:SmallEntities2023-09-012024-08-3110342921ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3110342921ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3110342921ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3110342921ns10:FullAccounts2023-09-012024-08-3110342921ns10:OrdinaryShareClass12023-09-012024-08-3110342921ns10:OrdinaryShareClass22023-09-012024-08-3110342921ns5:CurrentFinancialInstruments2024-08-3110342921ns5:CurrentFinancialInstruments2023-08-3110342921ns5:Non-currentFinancialInstruments2024-08-3110342921ns5:Non-currentFinancialInstruments2023-08-3110342921ns5:ShareCapital2024-08-3110342921ns5:ShareCapital2023-08-3110342921ns5:RetainedEarningsAccumulatedLosses2024-08-3110342921ns5:RetainedEarningsAccumulatedLosses2023-08-3110342921ns10:RegisteredOffice2023-09-012024-08-3110342921ns5:MotorVehicles2023-08-3110342921ns5:ComputerEquipment2023-08-3110342921ns5:MotorVehicles2023-09-012024-08-3110342921ns5:ComputerEquipment2023-09-012024-08-3110342921ns5:MotorVehicles2024-08-3110342921ns5:ComputerEquipment2024-08-3110342921ns5:MotorVehicles2023-08-3110342921ns5:ComputerEquipment2023-08-3110342921ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3110342921ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-3110342921ns10:OrdinaryShareClass12024-08-3110342921ns10:OrdinaryShareClass22024-08-31103429211ns10:Director12023-08-31103429211ns10:Director12022-08-31103429211ns10:Director12023-09-012024-08-31103429211ns10:Director12022-09-012023-08-31103429211ns10:Director12024-08-31103429211ns10:Director12023-08-31
REGISTERED NUMBER: 10342921 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st August 2024

for

DK Cardiology Limited

DK Cardiology Limited (Registered number: 10342921)






Contents of the Financial Statements
for the Year Ended 31st August 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


DK Cardiology Limited (Registered number: 10342921)

Balance Sheet
31st August 2024

31.8.24 31.8.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 29,806 36,449

CURRENT ASSETS
Debtors 5 29,507 30,495
Cash at bank 34,141 15,477
63,648 45,972
CREDITORS
Amounts falling due within one year 6 27,197 13,983
NET CURRENT ASSETS 36,451 31,989
TOTAL ASSETS LESS CURRENT
LIABILITIES

66,257

68,438

CREDITORS
Amounts falling due after more than one year 7 (23,447 ) (28,137 )

PROVISIONS FOR LIABILITIES (5,663 ) (6,925 )
NET ASSETS 37,147 33,376

CAPITAL AND RESERVES
Called up share capital 9 101 101
Retained earnings 37,046 33,275
SHAREHOLDERS' FUNDS 37,147 33,376

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st August 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 4th April 2025 and were signed by:



Dr D K Smith - Director


DK Cardiology Limited (Registered number: 10342921)

Notes to the Financial Statements
for the Year Ended 31st August 2024

1. COMPANY INFORMATION

DK Cardiology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10342921

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

DK Cardiology Limited (Registered number: 10342921)

Notes to the Financial Statements - continued
for the Year Ended 31st August 2024

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1st September 2023 36,475 776 37,251
Additions - 966 966
At 31st August 2024 36,475 1,742 38,217
DEPRECIATION
At 1st September 2023 608 194 802
Charge for year 7,173 436 7,609
At 31st August 2024 7,781 630 8,411
NET BOOK VALUE
At 31st August 2024 28,694 1,112 29,806
At 31st August 2023 35,867 582 36,449

5. DEBTORS
31.8.24 31.8.23
£    £   
Amounts falling due within one year:
Trade debtors 20,283 22,272
Other debtors 122 -
20,405 22,272

Amounts falling due after more than one year:
Worcester Cardiac Group LLP 9,102 8,223

Aggregate amounts 29,507 30,495

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Hire purchase contracts 4,690 4,690
Corporation tax payable 20,887 7,517
Directors' current accounts 28 344
Accrued expenses 1,592 1,432
27,197 13,983

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.8.24 31.8.23
£    £   
Hire purchase contracts 23,447 28,137

DK Cardiology Limited (Registered number: 10342921)

Notes to the Financial Statements - continued
for the Year Ended 31st August 2024

8. SECURED DEBTS

The following secured debts are included within creditors:

31.8.24 31.8.23
£    £   
Hire purchase contracts 28,137 32,827

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.24 31.8.23
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
101 101

The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The Ordinary A and Ordinary B shares rank pari passu in respect of capital distribution rights.

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st August 2024 and 31st August 2023:

31.8.24 31.8.23
£    £   
Dr D K Smith
Balance outstanding at start of year (344 ) (501 )
Amounts advanced 63,628 54,807
Amounts repaid (63,312 ) (54,650 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (28 ) (344 )

The loan is repayable on demand and no interest was charged during the year.

11. CONTROL

The ultimate controlling party is Dr Smith by virtue of holding 100% of the voting share capital.